AI assistant
Tevogen Bio Holdings Inc. — Director's Dealing 2025
Mar 14, 2025
33780_dirs_2025-03-14_705717f0-d032-4ea4-ac38-f3aa3f78d6f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tevogen Bio Holdings Inc. (TVGN)
CIK: 0001860871
Period of Report: 2025-03-12
Reporting Person: Flomenberg Neal (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-12 | Common Stock | S | 232968 | $1.09 | Disposed | 3595608 | Direct |
Footnotes
F1: The sales reported on this Form 4 were made solely to satisfy the payment of tax obligations relating to the vesting and subsequent settlement of restricted stock units. Such sales were not made at the discretion of the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.